Effect of Time to Dasatinib Initiation On Outcome of Imatinib-Intolerant Patients with Chronic-Phase Chronic Myelogenous Leukemia (Cp-Cml): Results From a European Observational Study (Forte; Ca180-211)

AuthID
 P-002-JK2
18
Author(s)
Morra, E
·
Michallet, M
·
Hellmann, A
·
Niederwieser, D
·
Schloegl, E
·
Bjoreman, M
·
Foryciarz, K
·
Ho, AY
·
Kuliczkowski, K
·
Ossenkoppele, G
·
Gozzini, A
·
Lurdes Guerra, ML
·
Verhoef, G
·
Mori, A
·
Pans, M
·
van Baardewijk, M
·
Luis Steegmann, JL
Tipo de Documento
Abstract
Year published
2011
Publicado
in BLOOD, ISSN: 0006-4971
Volume: 118, Número: 21, Páginas: 734-735 (2)
Conference
53Rd Annual Meeting and Exposition of the American-Society-Of-Hematology (Ash), Date: DEC 10-13, 2011, Location: San Diego, CA, Patrocinadores: Amer Soc Hematol
Indexing
Wos®
Publication Identifiers
Wos: WOS:000299597102284
Source Identifiers
ISSN: 0006-4971
Export Publication Metadata
Lista Marked
 Adicionar à lista Marked
Info
At this moment we don't have any links to full text documens.

Um espaço para investigadores e suas Instituições

Links Úteis

Ajuda

© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service